Welcome to our dedicated page for Compass Minerals Intl SEC filings (Ticker: CMP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Winter salt tonnage, brine extraction metrics, and crop-nutrition margins are scattered across hundreds of pages of Compass Minerals filings. Finding when executives file Compass Minerals insider trading Form 4 transactions or how mild winters affect revenue in the Compass Minerals quarterly earnings report 10-Q filing can feel overwhelming. If you have ever wondered, “How do I see Compass Minerals� environmental obligations line by line?� this page addresses that challenge head-on.
Stock Titan’s platform turns dense documents into clear insights. Our AI engine delivers Compass Minerals SEC filings explained simply: plain-English summaries, real-time alerts the moment a Compass Minerals Form 4 insider transactions real-time notice hits EDGAR, and side-by-side tables that link salt production data to segment earnings. Tap into instant Compass Minerals earnings report filing analysis, or ask natural questions such as “understanding Compass Minerals SEC documents with AI� and receive direct answers, citation links, and keyword search inside PDFs. Coverage spans every form�10-K, 10-Q, 8-K, DEF 14A, S-8—so you never miss a disclosure.
Ready to drill into what matters? Explore the Compass Minerals annual report 10-K simplified for volume trends, scan a Compass Minerals proxy statement executive compensation to benchmark pay vs. peers, or receive push alerts on Compass Minerals executive stock transactions Form 4. Material news? A single click opens the latest Compass Minerals 8-K material events explained. With AI-powered summaries, historical comparisons, and real-time updates, professionals save hours and make sharper decisions using the full breadth of Compass Minerals� regulatory disclosures.
Compass Minerals International, Inc. (CMP) filed a Form 4/A to correct a duplicate insider filing made on 1 July 2025. The amendment re-affirms that Director Joseph E. Reece received 2,209 deferred stock units on 30 June 2025 at a grant price of $0 as part of standard board compensation. Following the grant, Reece now directly owns 65,755 CMP shares and indirectly holds 21,000 shares via a trust. No derivative securities were involved and there are no changes to the underlying transaction details; the sole purpose of the Form 4/A is to replace an inadvertently duplicated submission.
The disclosure is routine, reflects non-cash compensation, and does not signal any strategic shift or financial impact for CMP.
Form 4 filing summary for Hilton Worldwide Holdings Inc. (HLT)
Director Jonathan Gray reported one transaction dated 06/27/2025. The filing shows the automatic acquisition of 4.757 common shares at a price of $0.00 per share. The shares represent dividend-equivalent rights that accrued on previously deferred share units in connection with Hilton’s quarterly dividend. After the transaction, Gray’s direct beneficial ownership stands at 8,430.268 common shares. No derivative securities were involved and no sales were reported.
The transaction is routine, reflects normal dividend reinvestment mechanics, and does not materially change the insider’s stake or signal a strategic shift.
Acacia Research Corp. (ACTG) � Form 4 filing: Director Gavin T. Molinelli received 8,380 shares of common stock on 30 Jun 2025 at an implied price of $3.58 per share. The stock grant was made in lieu of cash compensation for Q2-2025 board fees. Following the transaction, Molinelli’s total direct ownership increased to 150,987 shares. No dispositions or derivative transactions were reported, and no Rule 10b5-1 trading plan was indicated.
Because the shares were granted rather than purchased on the open market, the event signals board-level alignment but has limited immediate financial impact on the company. There is no effect on outstanding share count beyond routine equity compensation and no earnings or operational data were disclosed.
Acacia Research Corp. (ACTG) � Form 4 filing: Director Gavin T. Molinelli received 8,380 shares of common stock on 30 Jun 2025 at an implied price of $3.58 per share. The stock grant was made in lieu of cash compensation for Q2-2025 board fees. Following the transaction, Molinelli’s total direct ownership increased to 150,987 shares. No dispositions or derivative transactions were reported, and no Rule 10b5-1 trading plan was indicated.
Because the shares were granted rather than purchased on the open market, the event signals board-level alignment but has limited immediate financial impact on the company. There is no effect on outstanding share count beyond routine equity compensation and no earnings or operational data were disclosed.
Acacia Research Corp. (ACTG) � Form 4 filing: Director Gavin T. Molinelli received 8,380 shares of common stock on 30 Jun 2025 at an implied price of $3.58 per share. The stock grant was made in lieu of cash compensation for Q2-2025 board fees. Following the transaction, Molinelli’s total direct ownership increased to 150,987 shares. No dispositions or derivative transactions were reported, and no Rule 10b5-1 trading plan was indicated.
Because the shares were granted rather than purchased on the open market, the event signals board-level alignment but has limited immediate financial impact on the company. There is no effect on outstanding share count beyond routine equity compensation and no earnings or operational data were disclosed.
Hilton Worldwide Holdings Inc. (HLT) � Form 4 filing dated 07/01/2025
Director Charlene T. Begley reported a small automatic acquisition of 7.506 shares of common stock on 06/27/2025. The shares represent dividend-equivalent rights that accrued on previously deferred share units in connection with Hilton’s quarterly dividend. No cash was paid (transaction code “A�; price $0).
Following this de minimis transaction, Begley’s direct beneficial ownership rose to 14,676.445 shares. No derivative securities were involved, and no dispositions were reported. The filing was signed by attorney-in-fact Owen L. Wilcox.
The transaction is routine, carries minimal market impact, and primarily reflects ongoing alignment of director interests with shareholders through dividend reinvestment mechanisms.
Canadian Imperial Bank of Commerce (CIBC) is marketing Accelerated Return Notes® (ARNs®) linked to the performance of the Invesco S&P 500® Equal Weight ETF (RSP). Each note is issued at $10.00, carries a tenor of approximately 14 months, and offers a 300% participation rate in any positive price movement of RSP, but total upside is capped between $10.95 and $11.35 per unit (a gain of 9.5%-13.5%, to be fixed on the pricing date). Investors receive no periodic coupons and face 1-for-1 downside exposure; if RSP declines, principal is at risk up to a 100% loss.
The notes are senior unsecured obligations of CIBC and not listed on any exchange, implying limited secondary-market liquidity. Their initial estimated value will be below the public offering price due to built-in fees and hedging costs. Key risks disclosed include full downside risk, the creditworthiness of CIBC, valuation disparities if sold prior to maturity, and the lack of any direct ownership or dividend entitlement in the underlying ETF.
This structure may appeal to investors who expect a modest, capped rise in RSP over 14 months and who are comfortable substituting principal protection for amplified, but limited, participation.
Compass Minerals International, Inc. (NYSE: CMP) filed a Form SD for the fiscal year ended September 30 2024 to satisfy Rule 13q-1 requirements regarding payments to governments made in connection with the commercial development of minerals.
The company states that Rule 13p-1 (Conflict Minerals) is not applicable; therefore, no conflict-minerals report or exhibit is provided.
An attached Exhibit 2.01 � Resource Extraction Payment Report (not reproduced in the narrative) contains the actual payment schedules. All amounts were or will be presented in U.S. dollars using exchange rates as of September 30 2024.
Operating structure highlighted in the filing:
- Two reportable segments: Salt (road de-icing, consumer & industrial) and Plant Nutrition (specialty potash fertiliser).
- Eight production-stage mining properties located in the United States, Canada and the United Kingdom, including Cote Blanche (rock salt, LA), Goderich Mine & Plant (ON), Ogden projects (UT) and Winsford (UK).
- Two exploration-stage properties (Wynyard, Saskatchewan and the Atacama Desert, Chile); payment disclosure for these sites is deferred until the FY 2025 Form SD, pursuant to Item 2.01(b)(1).
No quantitative payment figures, earnings metrics or strategy updates appear in the text of the filing. The document therefore represents routine regulatory compliance rather than a material corporate development. Investors seeking precise payment amounts must consult Exhibit 2.01 once filed on EDGAR.
Compass Minerals (NYSE:CMP) filed an 8-K under Item 5.02 reporting that, effective June 26 2025, Chief Legal and Administrative Officer & Corporate Secretary Mary L. Frontczak departed the company. James D. Hughes has been appointed interim General Counsel and Corporate Secretary.
The filing provides no reason for the departure and discloses no severance or other compensatory arrangements. No additional operational or financial updates were included.
Compass Minerals International (CMP) Chief Commercial Officer Benjamin S. Nichols received a new grant of restricted stock units (RSUs) on June 24, 2025. The key details of this insider transaction include:
- Granted 5,084 RSUs that will vest in two equal annual installments on June 24, 2026 and June 24, 2027
- Currently holds 7,981 shares of common stock directly
- Owns an additional 249 shares indirectly through the company's 401(k) plan
This equity award appears to be part of the company's executive compensation program. Each RSU represents a contingent right to receive one share of common stock upon vesting. The grant was reported via Form 4 filing within the required two-business-day window, with the filing made through an attorney-in-fact on June 25, 2025.